Administrative and Engagement Core

行政和参与核心

基本信息

批准号：
10738440
负责人：
Juliet Iwelunmor
金额：
$ 19.84万
依托单位：
WASHINGTON UNIVERSITY
依托单位国家：
美国
项目类别：
财政年份：
2023
资助国家：
美国
起止时间：
2023-09-19 至 2028-08-31
项目状态：
未结题

来源：
https://reporter.nih.gov/project-details/10738440
关键词：
Acceleration Address Adoption Attention Award Cancer Control Cancer Vaccines Caring Cervical cancer vaccine Cessation of life Clinical Services Collaborations Communication Communities Community Outreach Country Creativeness Development Educational workshop Ensure Environment Equity Ethics Evaluation Fostering Foundations Goals Guidelines Health Health system Hepatitis B Vaccines Human Papilloma Virus Vaccine Human Resources Incidence Individual Infrastructure Intervention Logistics Malignant Neoplasms Malignant neoplasm of cervix uteri Malignant neoplasm of liver Medical Research Methods Modeling Nigeria Nigerian North Carolina Persons Prevention Process Protocols documentation Public Health Research Research Institute Research Personnel Resource-limited setting Role Societies Surveys Teleconferences Testing Training Translational Research Travel United States National Institutes of Health Universities Vaccines Visual impairment World Health Organization access disparities community engagement community involvement community setting cost crowdsourcing evidence base health goals implementation science implementation strategy improved mortality novel operation outreach programs response success symposium

Acceleration Address Adoption Attention Award Cancer Control Cancer Vaccines Caring Cervical cancer vaccine Cessation of life Clinical Services Collaborations Communication Communities Community Outreach Country Creativeness Development Educational workshop Ensure Environment Equity Ethics Evaluation Fostering Foundations Goals Guidelines Health Health system Hepatitis B Vaccines Human Papilloma Virus Vaccine Human Resources Incidence Individual Infrastructure Intervention Logistics Malignant Neoplasms Malignant neoplasm of cervix uteri Malignant neoplasm of liver Medical Research Methods Modeling Nigeria Nigerian North Carolina Persons Prevention Process Protocols documentation Public Health Research Research Institute Research Personnel Resource-limited setting Role Societies Surveys Teleconferences Testing Training Translational Research Travel United States National Institutes of Health Universities Vaccines Visual impairment World Health Organization access disparities community engagement community involvement community setting cost crowdsourcing evidence base health goals implementation science implementation strategy improved mortality novel operation outreach programs response success symposium

展开

项目摘要

Nigeria is at a crossroads in its cancer control response. On the one hand, the country remains an epicenter of a growing cancer crisis. On the other hand, there are existing guidelines (e.g., the National Cancer Control Plan2 by the Nigerian Ministry of Health, the Costing for Cervical Cancer Elimination in Nigeria by the World Health Organization,3 a Society-wide guideline for cervical cancer elimination,4 and a recent National Strategic Framework on vaccines for cancer control).5 These have accelerated the tempo and created new opportunities to achieve the country's vision for reducing the incidence and mortality of cancer in Nigeria. As a result, to support novel partnerships within and beyond traditional clinical services, including in community settings and non-health sector organizations, we propose the US-Nigerian Cancer Control Center for Research on Implementation Science and Equity (C3-RISE) Administration and Engagement Core (AEC). Our overarching goal is to improve cancer control in Nigeria and exert a sustained impact on public health in partnership with key stakeholders. Our proposed U54 Center brings together a transdisciplinary research team to meaningfully collaborate with key stakeholders, including individuals, communities, and local and state ministries of health. The U54 program will foster a Nigerian implementation science (IS) program to optimize the implementation of vaccines for cancer control efforts in Nigeria. The AEC will be responsible for the overall administration, coordination, and management of the Center and communication with the NIH. It will foster collaboration between researchers and key stakeholders and provide critical infrastructure for equitable implementation of evidence-based vaccines (i.e. human papillomavirus (HPV) vaccines for cervical cancer and hepatitis B (HepB) vaccines for liver cancer) for cancer control. We will also set a national and global standard for cutting-edge participatory IS research approaches9 in a resource-constrained setting that accelerates the adoption, adaptation, and sustainability of effective cancer control interventions in Nigeria. Our specific aims are: 1) To coordinate project management of the center wide-activities using agile methods; 2) To serve as a community engagement hub for IS in Nigeria using crowdsourcing methods; and 3) To evaluate Center's milestones and overall progress. By providing an infrastructure that facilitates Center-wide communications, operations, community outreach and evaluation, the AEC will serve as a central focal point to reinforce the overall vision of reducing the incidence and mortality of cancer while advancing the role of IS for equitable cancer control in Nigeria.

尼日利亚在其癌症控制反应中处于十字路口。一方面，该国仍然是癌症危机不断增长。另一方面，有现有的准则（例如，国家癌症控制尼日利亚卫生部计划2，全世界在尼日利亚消除宫颈癌的成本卫生组织3，《消除宫颈癌的社会指南》，4和最近的国家战略用于癌症控制疫苗的框架）。5它们加速了节奏并创造了新的机会为了实现该国降低尼日利亚癌症发病率和死亡率的愿景。结果，支持传统临床服务内外的新型伙伴关系，包括在社区环境和非健康部门组织，我们提出了美国尼日利亚癌症控制中心的研究中心实施科学与公平（C3升）管理与参与核心（AEC）。我们的总体目标是改善尼日利亚的癌症控制，并与主要利益相关者。我们提议的U54中心汇集了一个跨学科研究团队与主要利益相关者，包括个人，社区以及地方和州卫生部的合作。 U54计划将培养尼日利亚实施科学（IS）计划，以优化实施尼日利亚癌症控制工作的疫苗。 AEC将负责总体管理，中心的协调和管理以及与NIH的沟通。它将促进合作研究人员和主要利益相关者之间循证疫苗（即宫颈癌和肝炎的人乳头瘤病毒（HPV）疫苗（HEPB）肝癌的疫苗）控制癌症。我们还将为尖端设定国家和全球标准参与性是研究方法9 尼日利亚有效控制干预措施的适应性和可持续性。我们的具体目的是：1）使用敏捷方法协调中心广泛活动的项目管理； 2）作为一个社区使用众包方法在尼日利亚的参与枢纽； 3）评估中心的里程碑和总体进步。通过提供促进中心沟通，操作的基础架构，社区宣传和评估，AEC将成为增强整体愿景的中心焦点降低癌症的发病率和死亡率，同时推进IS在尼日利亚。